Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	34.22B -24.3%
Revenue (ttm)	4.58B -1.3%
Net Income	1.62B -11.7%
EPS	2.07 -11.7%
Shares Out	785.72M
PE Ratio	21.06
Forward PE	18.40
Dividend	1.20 (2.76%)
Ex-Dividend Date	May 27, 2026

Volume	5,118,500
Open	41.73
Previous Close	43.55
Day's Range	41.73 - 44.50
52-Week Range	37.50 - 71.51
Beta	-0.21
Analysts	Strong Buy
Price Target	64.70 (+47.55%)
Earnings Date	Aug 14, 2026

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,785
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2025, SHE:300832's revenue was 4.58 billion, an increase of 0.91% compared to the previous year's 4.54 billion. Earnings were 1.62 billion, a decrease of -11.39%.

Analyst Summary

According to 13 analysts, the average rating for 300832 stock is "Strong Buy." The 12-month stock price target is ¥64.70, which is an increase of 47.55% from the latest price.

Price Target

¥64.70

(47.55% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 15, 2026

Data Sources Report a data error